San Francisco, California, March 08, 2018: A recent report by TMR Research, titled, “Blood Culture Test Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017 – 2025” offers a detailed outlook of this market by reviewing different factors.
Governmental initiatives such as timely medical reimbursements and increased funding for research and development activities are some of the prominent driving factors for the global blood culture test market. A high risk of blood infection may arise mainly when a person has been affected by diseases such as HIV, AIDS, cancer, and diabetes. As such chronic issues are on the rise all over the globe, their occurrence is a key catalyst for demand of blood culture tests.
Get Sample Copy of this Report @
A significant rise in the number of surgeries that require carrying out blood culture tests has been noted owing to proliferation of such chronic issues. This has consequently uplifted the global blood culture tests market. Blood cultures are also increasingly being drawn from infants and newborns, who might have been affected with an infection or fever. This is carried out as a helping hand for diagnosis of health issues faced by the infants.
However, blood culture tests might produce a few side effects in some people, such as skin infections, excessive bleeding, hematoma, and fainting. Such side effects are prominent restraints for the global blood culture test market. Incidences like these might discourage patients and other concerned people from getting these tests done. However, several innovations are being carried out to make the blood culture tests safe, which is expected to dilute the effects of obstacles affecting the market.
The global blood culture test market showcases remarkable potential when it comes to recent innovations. A case in point is the unique method developed in a research study conducted at the University of Nebraska Medical Center. This technique reduced contamination caused while drawing out blood.
The global blood culture test market is mainly segmented on the basis of technology and regions. Under technology, manual blood culture tests and automated blood culture tests are two prime segments. The manual blood culture tests have seen higher preference owing to being less expensive and requiring less operational knowledge.
Geography-wise, the global blood culture test market is segmented into Europe, North America, the Middle East and Africa, Latin America, and Asia Pacific. At present, the market shows is most developed in North America, owing to the presence of well-established players. After North America, Europe is anticipated to attract high demand for blood culture tests in the near future. This is mainly due to a rapid development of healthcare infrastructure in leading countries such as U.K., France, and Germany belonging to the European region. However, Asia Pacific is prognosticated to overtake both regions by the virtue of high growth rate registered in the upcoming years, owing to a dramatic rise in infectious diseases.
The global blood culture test market showcases a highly competitive scenario as a result of various small as well as large-scale businesses aiming to grab top spots. Players are offering automated blood culture tests and also coming up with safer and effective products to up sales in the market New players are seen developing cost-effective blood culture tests, in order to compete against existing businesses. Thermo Fisher Scientific, Inc., Roche Diagnostics, Luminex Corporation, Becton, Dickinson and Company, Bruker Corporation, Danaher Corporation, Abbott, and Alere are some of the key players operating in the global blood culture test market.